|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 983 studies with search of: | squamous cell carcinoma |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy
|
||||
| 2 | Active, not recruiting |
Dasatinib in Patients With Head and Neck Squamous Cell Carcinoma
|
||||
| 3 | Not yet recruiting |
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
|
||||
| 4 | Recruiting |
Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma
|
||||
| 5 | Completed |
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
|
||||
| 6 | Recruiting |
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar
|
||||
| 7 | Completed |
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
|
||||
| 8 | Active, not recruiting |
Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer
|
||||
| 9 | Recruiting |
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
|
||||
| 10 | Active, not recruiting |
Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
|
||||
| 11 | Completed |
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
|
||||
| 12 | Terminated |
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
|
||||
| 13 | Recruiting |
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
|
||||
| 14 | Recruiting |
Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)
|
||||
| 15 | Active, not recruiting |
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
|
||||
| 16 | Recruiting |
Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip
|
||||
| 17 | Active, not recruiting |
ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
|
||||
| 18 | Recruiting |
An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)
|
||||
| 19 | Recruiting |
MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck
|
||||
| 20 | Recruiting |
A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|